Name | 2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid |
---|---|
Synonyms |
2-{4-[2-(Trifluoromethyl)benzoyl]-1-piperazinyl}-1,3-thiazole-5-carboxylic acid
5-Thiazolecarboxylic acid, 2-[4-[2-(trifluoromethyl)benzoyl]-1-piperazinyl]- 2-{4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl}-1,3-thiazole-5-carboxylic acid 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylic acid |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 578.2±60.0 °C at 760 mmHg |
Molecular Formula | C16H14F3N3O3S |
Molecular Weight | 385.361 |
Flash Point | 303.5±32.9 °C |
Exact Mass | 385.070801 |
PSA | 101.98000 |
LogP | 0.96 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.597 |
HS Code | 2934100090 |
---|
~% 916888-64-7 |
Literature: MERCK FROSST CANADA LTD. Patent: WO2006/130986 A1, 2006 ; Location in patent: Page/Page column 39 ; WO 2006/130986 A1 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |